Development of a three-layer consecutive gene delivery system for enhanced bone regeneration

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Nanotechnology

Background:

• Effective bone regeneration requires precise control over the timing of transcription factor expression.
• Current methods for inducing osteogenic differentiation face challenges in achieving temporal control of gene delivery.

Purpose of the Study:

• To develop and evaluate a three-layer consecutive gene delivery system (T-CGDS) for sequential gene delivery into human mesenchymal stem cells (hMSCs).
• To promote bone regeneration and osteogenic differentiation through controlled release of key transcription factors.

Main Methods:

• Fabrication of a three-layered nanocomposite using gold nanoparticles of varying sizes (80 nm, 50 nm, 20 nm) and specific pDNA (ATF4, SP7, RUNX2).
• Sequential coating with heparin-conjugated Pluronic F-127 (HP-F127) to create the T-CGDS structure.
• In vitro and in vivo testing of T-CGDS for gene expression timing, release kinetics, and osteogenic differentiation induction in hMSCs.

Main Results:

• The T-CGDS, measuring 350-450 nm, demonstrated sustained gene release for over 8 days with decreasing size.
• Sequential gene expression was observed in hMSCs: RUNX2 (outer layer), followed by SP7 (middle), and ATF4 (core).
• The T-CGDS significantly enhanced bone differentiation and regeneration in both in vitro and in vivo models.

Conclusions:

• The T-CGDS provides a promising platform for temporally controlled gene delivery in regenerative medicine.
• Targeted delivery of ATF4 via T-CGDS is crucial for facilitating osteogenic differentiation and bone repair.
• This nanotechnology approach offers a significant advancement in strategies for bone regeneration.